AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

MED BRIEFS.(HEALTH & MEDICINE)

Investor's Business Daily

| October 04, 2004 | COPYRIGHT 2004 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Merck Steady -- After The Fall

The drug making giant's stock stabilized somewhat early Friday, a day after shares plummeted 28% when Merck pulled its blockbuster arthritis drug, Vioxx, from the global market because new data from a clinical trial found an increased risk of heart attack and stroke.

New Trial Requested Of Allergan

U.S. regulators won't approve Allergan's experimental treatment for the skin disorder psoriasis based on the data submitted. The Food and Drug Administration wants the firm to conduct a new clinical trial to prove the treatment is not inferior to other treatments for severe psoriasis.

Feds Ease Manufacturing Rules

Drug makers won't need regulatory approval for every change in their manufacturing processes under new guidelines designed to prevent supply ...

Related articles from newspapers, magazines, journals, and more
Hollis-Eden Reports Positive Results From Malaria Phase II Clinical Trial With...
Press release article from: Business Wire November 21, 2002 700+ words
...2002 The Company Also Reports Positive Results with HE2000 in a Preclinical...HEPH) today announced positive results from a Phase II clinical...results were very similar to positive results reported previously in malaria...
ONCOLYTICS BIOTECH Reports Positive Results.
Press release article from: M2 Presswire June 6, 2007 700+ words
...6 June 2007-NASDAQNEWS: ONCOLYTICS BIOTECH Reports Positive Results(C)1994-2007 M2 COMMUNICATIONS LTD RDATE...its cancer treatment candidate Reolysin showed positive results in an early-stage study. The drug showed anti...
Oncolytics Reports Positive Results From Its Phase I Clinical Trial of REOLYSIN.
Press release article from: M2 Presswire June 5, 2007 700+ words
...June 2007-EIExplorationInvestor: Oncolytics Reports Positive Results From Its Phase I Clinical Trial of REOLYSIN...ONC, NASDAQ:ONCY) announced today June 5th positive results from its U.S. Phase I clinical trial examining...
ALEXION REPORTS POSITIVE RESULTS FROM AEGIS REGISTRATION STUDY.(Clinical report)
News wire article from: AsiaPulse News December 9, 2008 700+ words
...statement. Contact details below.) Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese...Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported positive results from AEGIS, an open-label registration study...
Mayo reports positive results with molecular breast imaging.
Magazine article from: Diagnostic Update January 20, 2005 700+ words
Mayo reports positive results with molecular breast imaging By KAREN YOUNG Diagnostics & Imaging Week Staff Writer Mayo Clinic (Rochester, Minnesota...
Kamada reports positive results in cystic fibrosis study.
Magazine article from: Israel Business Arena October 15, 2008 700+ words
Byline: Gali Weinreb Kamada Ltd. (TASE: KMDA) reports positive results of its Phase II clinical trial of its Alpha-1 Antitrypsin (AAT) protein for the treatment of cystic fibrosis. The company...
FlexDigital Reports Positive Results Using Exstream's Dialogue...
Press release article from: Business Wire August 21, 2007 700+ words
...announced that FlexDigital, a full service mailing and marketing services firm located in Birmingham, AL, reports positive results using its Dialogue software as a common platform to produce a full spectrum of high-volume and on-demand...
IsoTis Reports Positive Results Allox(TM) Phase 2 Trial - Establishes Complete...
Press release article from: PR Newswire July 9, 2004 700+ words
...California, July 9 /PRNewswire/ -- IsoTis OrthoBiologics (SWX/Euronext Amsterdam: ISON; TSX: ISO) reports positive results for the Phase 2 dose escalation trial of its chronic wound treatment product Allox(TM). Allox(TM) is...
Galway Resources Reports Positive Results from its Infill Drilling Program at...
Press release article from: M2 Presswire December 6, 2007 700+ words
M2 PRESSWIRE-6 December 2007-Galway Resources: Galway Resources Reports Positive Results from its Infill Drilling Program at the Indian Springs Open-Pittable Tungsten Project(C)1994-2007 M2 COMMUNICATIONS LTD...
Hollis-Eden reports positive results for prostate treatment.(BIOTECH)(Financial...
Magazine article from: San Diego Business Journal Chambers, Heather October 15, 2007 700+ words
Hollis-Eden Reports Positive Results For Prostate Cancer Treatment: Preclinical animal studies involving a cancer drug candidate being developed by Hollis-Eden Pharmaceuticals...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA